Pharmaceutical giant GlaxoSmithKline (GSK) is planning to acquire the over-the-counter arm of global healthcare group Novartis.
The Commerce Commission is currently considering GSK’s application, the commission says in a press release.
{iframe}http://www.nzdoctor.co.nz/news/2014/october-2014/13/gsk-plans-acquisition-of-novartis-otc-line.aspx{/iframe}